Development of a negamycin analogue targeting the translational machinery in gram-negative drug-resistant pathogens for the treatment of infections
Ended Project Grant Awarded Last action
- Award ID
- W81XWH1710180
- Recipient
-
Appili Therapeutics Inc. UEI M6M7UQZCXG47
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,226,658
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$1 | |
| Original award | $1,226,659 |
Quick answers
Who received award W81XWH1710180?
W81XWH1710180 was awarded to Appili Therapeutics Inc. by Medical Command (Department of the Army) on September 30, 2017.
How much is award W81XWH1710180 worth?
$1,226,658 has been obligated on W81XWH1710180.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award